Express Pharma
Home  »  Latest Updates  »  UK regulator says COVID-19 prevention trial of hydroxychloroquine can resume

UK regulator says COVID-19 prevention trial of hydroxychloroquine can resume

The decision came after the drug was found in another UK trial to have no benefit for patients already infected with COVID-19, the pandemic disease caused by the new coronavirus

0 892
Read Article

A global trial designed to find out whether the anti-malaria drug hydroxychloroquine can prevent infection with COVID-19 is to restart after getting approval from the UK medicines agency.

The Medicines and Healthcare Products Regulatory Agency (MHRA) decision on the trial, which is known as the COPCOV trial, comes after the drug was found in another UK trial to have no benefit for patients already infected with COVID-19, the pandemic disease caused by the new coronavirus.

Leave A Reply

Your email address will not be published.

 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image